114 related articles for article (PubMed ID: 4788211)
1. Influence of allopurinol on drug metabolism in man.
Rawlins MD; Smith SE
Br J Pharmacol; 1973 Aug; 48(4):693-8. PubMed ID: 4788211
[TBL] [Abstract][Full Text] [Related]
2. The influence of allopurinol and size of dose on the metabolism of phenylbutazone in patients with gout.
Horwitz D; Thorgeirsson SS; Mitchell JR
Eur J Clin Pharmacol; 1977 Oct; 12(2):133-6. PubMed ID: 923626
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man.
O'Reilly RA; Levy G
J Pharm Sci; 1970 Sep; 59(9):1258-61. PubMed ID: 5469787
[No Abstract] [Full Text] [Related]
4. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.
Banfield C; O'Reilly R; Chan E; Rowland M
Br J Clin Pharmacol; 1983 Dec; 16(6):669-75. PubMed ID: 6661352
[TBL] [Abstract][Full Text] [Related]
5. The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.
Pond SM; Graham GG; Wade DN; Sudlow G
Aust N Z J Med; 1975 Aug; 5(4):324-8. PubMed ID: 52353
[TBL] [Abstract][Full Text] [Related]
6. Warfarin-phenylbutazone interaction in man: a long term multiple dose study.
Schary WL; Lewis RJ; Rowland M
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):663-72. PubMed ID: 1153844
[TBL] [Abstract][Full Text] [Related]
7. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
O'Reilly RA; Trager WF; Motley CH; Howald W
J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses.
Sioufi A; Colussi D; Caudal F; Schoeller JP; Massias P
J Pharm Sci; 1980 Dec; 69(12):1413-6. PubMed ID: 7463328
[TBL] [Abstract][Full Text] [Related]
10. Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics.
Löffler W; Landthaler R; de Vries JX; Walter-Sack I; Ittensohn A; Voss A; Zöllner N
Clin Investig; 1994 Dec; 72(12):1071-5. PubMed ID: 7711418
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of coumarin anticoagulants XLV: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin and phenylbutazone in rats.
Yacobi A; Lai CM; Levy G
J Pharm Sci; 1980 Jan; 69(1):14-20. PubMed ID: 7354432
[No Abstract] [Full Text] [Related]
12. Allopurinol influences aminophenazone elimination.
Barry M; Feely J
Clin Pharmacokinet; 1990 Aug; 19(2):167-9. PubMed ID: 2379382
[TBL] [Abstract][Full Text] [Related]
13. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
O'Reilly RA
Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
[TBL] [Abstract][Full Text] [Related]
14. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
He J; Shibukawa A; Tokunaga S; Nakagawa T
J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
[TBL] [Abstract][Full Text] [Related]
15. Interaction between warfarin and nonsteroidal anti-inflammatory drugs (NSAIDs) in rats.
Sancilio LF; Taylor MA; Mathur PP; Crowe JT
Life Sci; 1985 Mar; 36(11):1041-50. PubMed ID: 3974406
[TBL] [Abstract][Full Text] [Related]
16. The effect of malnutrition on the pharmacokinetics of phenylbutazone.
Krishnaswamy K; Ushasri V; Naidu NA
Clin Pharmacokinet; 1981; 6(2):152-9. PubMed ID: 7214778
[TBL] [Abstract][Full Text] [Related]
17. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
18. An in vitro study of drug displacement interactions: warfarin-salicylate and warfarin-phenylbutazone.
Aarons LJ; Schary WL; Rowland M
J Pharm Pharmacol; 1979 May; 31(5):322-30. PubMed ID: 37303
[TBL] [Abstract][Full Text] [Related]
19. Failure of indomethacin and warfarin to interact in normal human volunteers.
Vesell ES; Passananti GT; Johnson AO
J Clin Pharmacol; 1975 Jul; 15(7):486-95. PubMed ID: 1150903
[TBL] [Abstract][Full Text] [Related]
20. Enhanced elimination of warfarin during treatment with cholestyramine.
Jähnchen E; Meinertz T; Gilfrich HJ; Kersting F; Groth U
Br J Clin Pharmacol; 1978 May; 5(5):437-40. PubMed ID: 656283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
